| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/03/2014 | CA2876240A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/02/2014 | US20140005394 Preparation method of intermediate of sitagliptin |
| 01/02/2014 | US20140005393 Sulfonamide compounds having trpm8 antagonistic activity |
| 01/02/2014 | US20140005370 Molecular glasses with functionalizable groups |
| 01/02/2014 | US20140005213 Triazolopyridine compounds as pim kinase inhibitors |
| 01/02/2014 | US20140005210 Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors |
| 01/02/2014 | US20140005209 Methods of Using Selective Chemotherapeutic Agents for Targeting Tumor Cells |
| 01/02/2014 | US20140005201 Tricyclic imidazole compounds as PDE10 inhibitors |
| 01/02/2014 | US20140005200 6,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-4-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
| 01/02/2014 | US20140005198 Raf kinase modulators and methods of use |
| 01/02/2014 | US20140005193 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 01/02/2014 | US20140005190 Compounds and methods of use |
| 01/02/2014 | US20140005189 Novel 6-triazolopyridazine sulfanyl benzothiazole derivatives as met inhibitors |
| 01/02/2014 | US20140005188 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors |
| 01/02/2014 | US20140005183 Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2 Inhibitors |
| 01/02/2014 | US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders |
| 01/02/2014 | US20140005169 Bromodomain inhibitors and uses thereof |
| 01/02/2014 | US20140005168 5-azaindazole compounds and methods of use |
| 01/02/2014 | US20140005167 Kinase inhibitors and method of treating cancer with same |
| 01/02/2014 | US20140005166 Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
| 01/02/2014 | US20140005155 Organic compounds |
| 01/02/2014 | US20140005146 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| 01/02/2014 | US20140005103 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/02/2014 | US20140004506 Membrane-Based Lateral Flow Assay Devices that Utilize Phosphorescent Detection |
| 01/01/2014 | EP2679590A1 Processes for the Preparation of Sitagliptin and Pharmaceutically acceptable Salts thereof |
| 01/01/2014 | EP2679589A1 Compounds having indolocarbazole ring structure, and organic electroluminescent elements |
| 01/01/2014 | EP2679583A1 Mesoionic pesticides |
| 01/01/2014 | EP2678341A1 Alpha helix mimetics and methods relating thereto |
| 01/01/2014 | EP2678340A1 Preparation of bicyclic guanidine salts in an aqueous media |
| 01/01/2014 | CN103492391A Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| 01/01/2014 | CN103492390A Fluorophenyl bicyclic heteroaryl compounds |
| 01/01/2014 | CN103492389A Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors |
| 01/01/2014 | CN103492374A Pyrazolidin-3-one derivatives |
| 01/01/2014 | CN103492372A Androgen receptor modulating carboxamides |
| 01/01/2014 | CN103483344A Method for synthesizing oxindole spiro compound |
| 01/01/2014 | CN103483343A Compounds for inhibiting mitotic progression |
| 01/01/2014 | CN103483342A Process for the synthesis of E1 activating enzyme inhibitors |
| 01/01/2014 | CN103483341A 2, 4-pyrrolidine-diketone compounds and synthesis method thereof |
| 01/01/2014 | CN103483340A Synthetic method for sitagliptin |
| 01/01/2014 | CN103483267A Diverse arylimidazole quaternary ammonium salt, preparation method and application thereof |
| 01/01/2014 | CN103479730A Method for synchronously separating lotus leaf flavone and chlorophyll from fresh lotus leaves |
| 01/01/2014 | CN102686593B Copper phthalocyanine benzyl sulfone compound and derivative thereof |
| 01/01/2014 | CN102066376B Anhydrous crystal form of orvepitant maleate |
| 12/31/2013 | US8618288 Pyrimidine compounds as serotonin receptor modulators |
| 12/31/2013 | US8618281 Geometric synthesis of porphyrin rods |
| 12/31/2013 | US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 12/31/2013 | US8618121 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors |
| 12/31/2013 | US8618117 Amino-heterocyclic compounds |
| 12/31/2013 | US8618114 Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof |
| 12/31/2013 | US8618110 Compositions and methods for apoptosis modulators |
| 12/31/2013 | US8618107 Pyridone and aza-pyridone compounds and methods of use |
| 12/31/2013 | US8618103 Inhibitors of JAK |
| 12/31/2013 | US8618101 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 12/31/2013 | US8618089 Substituted porphyrins |
| 12/31/2013 | CA2647116C Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands |
| 12/31/2013 | CA2602965C Tricyclic spiro derivatives as crth2 modulators |
| 12/27/2013 | WO2013192556A2 Salt crystals |
| 12/27/2013 | WO2013192306A1 Positive allosteric modulators of mglur2 |
| 12/27/2013 | WO2013192301A1 Imidazo bicyclic imminium compounds as antitumor agents |
| 12/27/2013 | WO2013192273A1 Heteroaryl compounds and methods of use thereof |
| 12/27/2013 | WO2013192229A1 Substituted pyridine azolopyrimidine - 5 - (6h) - one compounds |
| 12/27/2013 | WO2013191965A1 Reversible covalent pyrrolo- or pyrazolopyrimidines useful for the treatment cancer and autoimmune diseases |
| 12/27/2013 | WO2013191113A1 Fused heterocyclic compound |
| 12/27/2013 | WO2013191112A1 Fused heterocyclic compound |
| 12/27/2013 | WO2013190123A1 Pyrimidinone derivatives as antimalarial agents |
| 12/27/2013 | WO2013189905A1 Pyrrolopyrazone inhibitors of tankyrase |
| 12/27/2013 | WO2013189237A1 Andrographolide analogue and application of andrographolide analogue to treatment |
| 12/27/2013 | CA2877473A1 Imidazo bicyclic imminium compounds as antitumor agents |
| 12/27/2013 | CA2877149A1 Substituted pyridine azolopyrimidine-5-(6h)-one compounds |
| 12/27/2013 | CA2877089A1 Novel 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof |
| 12/27/2013 | CA2877034A1 Pyrimidinone derivatives as antimalarial agents |
| 12/27/2013 | CA2876979A1 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| 12/27/2013 | CA2876969A1 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| 12/27/2013 | CA2876001A1 Salt crystals |
| 12/26/2013 | US20130345273 Reversal of drug-induced neuromuscular block using novel molecular containers |
| 12/26/2013 | US20130345243 1h-pyrollo[3,2-d]pyrimidinedione derivatives |
| 12/26/2013 | US20130345232 Methods and compositions for treating a subject for a lymphatic malformation |
| 12/26/2013 | US20130345228 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
| 12/26/2013 | US20130345226 Pyrrolopyrazone inhibitors of tankyrase |
| 12/26/2013 | US20130345224 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 12/26/2013 | US20130345223 Compounds and methods for treating tuberculosis infection |
| 12/26/2013 | US20130345219 Triazinone and diazinone derivatives useful as hsp90 inhibitors |
| 12/26/2013 | US20130345215 Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase |
| 12/26/2013 | US20130345214 Lipoxygenase Inhibitors |
| 12/26/2013 | US20130345206 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| 12/26/2013 | US20130345205 Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors |
| 12/26/2013 | US20130345204 Substituted bicyclic cycloalkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors |
| 12/26/2013 | US20130345203 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| 12/26/2013 | US20130345200 Indoles |
| 12/26/2013 | US20130345195 Benzodioxane inhibitors of leukotriene production |
| 12/26/2013 | US20130345194 Substituted cyclopentyl-azines as casr-active compounds |
| 12/26/2013 | US20130345192 Heterocyclic tyrosine kinase inhibitors |
| 12/26/2013 | US20130344061 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
| 12/26/2013 | US20130344031 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 12/25/2013 | EP2676961A1 Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 12/25/2013 | EP2676960A1 Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 12/25/2013 | EP2676959A1 Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 12/25/2013 | EP2675809A1 Process for preparing silica particles containing a phthalocyanine derivative by microwave irradiation, said particles and uses thereof |
| 12/25/2013 | EP2675808A2 Process for pemetrexed disodium |
| 12/25/2013 | EP2675807A1 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d]pyrimidin- 4 - one derivatives their use as pde9a inhibitors |